Please provide your email address to receive an email when new articles are posted on . Proteinuria levels don’t predict lupus nephritis type, suggesting separate study approaches are needed. Distinct ...
Lupkynis™ (voclosporin) was approved by the U.S. Food and Drug Administration (FDA) to treat adults with lupus nephritis in January 2021. Lupus nephritis is a type of kidney disease caused by ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback